10 questions health leaders are asking about the Great Healthcare Plan — and what it means for cost and coverage
Get clear, expert-backed answers to the biggest questions surrounding the Great Healthcare Plan, with insights from Emma Wager of KFF and industry experts including Jeffrey Casberg, Lindsay Bealor Greenleaf and Luke Greenwalt. This FAQ breaks down what proposed changes to drug pricing, PBMs, subsidies and insurance coverage could mean for your organization — and what to watch as policies take shape.
As policymakers continue to outline what has been described as a “Great Healthcare Plan,” health systems and payers are trying to understand what it could mean for coverage, drug pricing and overall costs.